Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain

Journal of Cell Biology - Tập 170 Số 3 - Trang 477-485 - 2005
Lynda M. Stuart1,2, Jiusheng Deng3, Jessica M. Silver3, Kazue Takahashi1, A. Shaw3, Elizabeth J. Hennessy1, R. Alan B. Ezekowitz1, Kathryn J. Moore3
11Laboratory of Developmental Immunology, Department of Pediatrics
23Medical Research Council Centre for Inflammation Research, University of Edinburgh, Edinburgh EH8 9AG, Scotland, UK
32Lipid Metabolism Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114

Tóm tắt

Phagocyte recognition and clearance of bacteria play essential roles in the host response to infection. In an on-going forward genetic screen, we identify the Drosophila melanogaster scavenger receptor Croquemort as a receptor for Staphylococcus aureus, implicating for the first time the CD36 family as phagocytic receptors for bacteria. In transfection assays, the mammalian Croquemort paralogue CD36 confers binding and internalization of Gram-positive and, to a lesser extent, Gram-negative bacteria. By mutational analysis, we show that internalization of S. aureus and its component lipoteichoic acid requires the COOH-terminal cytoplasmic portion of CD36, specifically Y463 and C464, which activates Toll-like receptor (TLR) 2/6 signaling. Macrophages lacking CD36 demonstrate reduced internalization of S. aureus and its component lipoteichoic acid, accompanied by a marked defect in tumor necrosis factor-α and IL-12 production. As a result, Cd36−/− mice fail to efficiently clear S. aureus in vivo resulting in profound bacteraemia. Thus, response to S. aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain, which initiates TLR2/6 signaling.

Từ khóa


Tài liệu tham khảo

2000, Nature., 405, 1015, 10.1038/35016636

2004, Nat. Rev. Immunol., 4, 499, 10.1038/nri1391

2000, Nat. Immunol., 1, 533, 10.1038/82797

2003, J. Neurosci., 23, 2665, 10.1523/JNEUROSCI.23-07-02665.2003

2004, Science., 304, 1014, 10.1126/science.1096158

1994, FEBS Lett., 351, 41, 10.1016/0014-5793(94)00814-0

1997, J. Exp. Med., 186, 1487, 10.1084/jem.186.9.1487

1994, Proc. Natl. Acad. Sci. USA., 91, 1863, 10.1073/pnas.91.5.1863

1993, J. Biol. Chem., 268, 11811, 10.1016/S0021-9258(19)50272-1

2001, J. Clin. Invest., 108, 785, 10.1172/JCI14006

1999, Science., 284, 1991, 10.1126/science.284.5422.1991

2003, J. Exp. Med., 197, 1107, 10.1084/jem.20021787

1997, J. Exp. Med., 186, 1431, 10.1084/jem.186.9.1431

2005, Nature., 433, 523, 10.1038/nature03253

1999, Science., 284, 1313, 10.1126/science.284.5418.1313

1991, Proc. Natl. Acad. Sci. USA., 88, 7844, 10.1073/pnas.88.17.7844

2000, Nat. Med., 6, 41, 10.1038/71517

2004, J. Biol. Chem., 280, 3989

2002, J. Biol. Chem., 277, 47834, 10.1074/jbc.M207873200

2003, Infect. Immun., 71, 3280, 10.1128/IAI.71.6.3280-3284.2003

1999, J. Biol. Chem., 274, 33419, 10.1074/jbc.274.47.33419

2000, Blood., 96, 3231, 10.1182/blood.V96.9.3231

2004, J. Biol. Chem., 279, 10643, 10.1074/jbc.M311735200

2002, J. Biol. Chem., 277, 47373, 10.1074/jbc.M208788200

2002, Eur. J. Immunol., 32, 3337, 10.1002/1521-4141(2002012)32:12<3337::AID-IMMU3337>3.0.CO;2-I

2004, Immunobiology., 209, 39, 10.1016/j.imbio.2004.02.004

1988, J. Infect. Dis., 157, 584, 10.1093/infdis/157.3.584

1989, Cell., 58, 95, 10.1016/0092-8674(89)90406-6

2002, Nature., 416, 644, 10.1038/nature735

1995, J. Exp. Med., 181, 1857, 10.1084/jem.181.5.1857

1992, J. Clin. Invest., 90, 1513, 10.1172/JCI116019

2003, J. Biol. Chem., 278, 15587, 10.1074/jbc.M212829200

1999, J. Biol. Chem., 274, 17406, 10.1074/jbc.274.25.17406

2004, J. Exp. Med., 199, 1379, 10.1084/jem.20032207

1996, J. Biol. Chem., 271, 22315, 10.1074/jbc.271.37.22315

2000, J. Exp. Med., 191, 147, 10.1084/jem.191.1.147

2004, Microbes Infect., 6, 1368, 10.1016/j.micinf.2004.08.016

1999, Nature., 401, 811, 10.1038/44605

2004, Science., 305, 1153, 10.1126/science.1099153